Monday, April 1, 2019

Cipla signs $22 mn pact with Pulmatrix Inc for new asthma drug

Cipla signs $22 mn pact with Pulmatrix Inc for new asthma drug Pulmazole is an inhaled anti-fungal formulation of itraconazole aimed at treating allergic bronchopulmonary aspergillosis (ABPA) in asthma patients.

from Moneycontrol Business News https://ift.tt/2TNWWab

No comments:

Post a Comment

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...